Cargando…

Beyond natural targets: chemical synthesis reprograms the target specificity of rapamycin

Detalles Bibliográficos
Autor principal:	Zhang, Ziyang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2022
Materias:	RESEARCH HIGHLIGHT
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9701095/ https://www.ncbi.nlm.nih.gov/pubmed/36452430 http://dx.doi.org/10.1093/nsr/nwac039

Ejemplares similares

Going beyond genetics to discover cancer targets
por: Sandoval, Gabriel J., et al.
Publicado: (2017)

Starving out brain tumors: a reprogrammed lysine catabolism serves as a novel target for glioblastoma treatment
por: Gül, Désirée, et al.
Publicado: (2023)

Memory of Chirality as a Prominent Pathway for the Synthesis of Natural Products through Chiral Intermediates
por: Hardwick, Tomas, et al.
Publicado: (2018)

Tumor‐derived extracellular vesicles and particles (EVPs): pivotal vectors in driving metabolic reprogramming
por: Su, Xinming, et al.
Publicado: (2023)

Targeting FMRP: A new window for cancer immunotherapy
por: Zhang, Yaguang, et al.
Publicado: (2023)

Beyond proteins: Ubiquitylation of lipopolysaccharide to fight bacteria
por: Gong, Yanqiu, et al.
Publicado: (2021)

Beyond the bowel – chaos caused by leaky barriers
por: Kattner, Aila Akosua
Publicado: (2023)

Plasmacytoid, conventional, and monocyte-derived dendritic cells undergo a profound and convergent genetic reprogramming during their maturation
por: Vu Manh, Thien-Phong, et al.
Publicado: (2013)

PI3K-PANK4: a new target for de novo synthesis of coenzyme A
por: Guan, Jizhong, et al.
Publicado: (2022)

Phage display: development of nanocarriers for targeted drug delivery to the brain
por: Bakhshinejad, Babak, et al.
Publicado: (2015)

Antigen targeting to dendritic cells: Still a place in future immunotherapy?
por: Stoitzner, Patrizia, et al.
Publicado: (2022)

Regenerative potential of targeting glycogen synthase kinase-3 signaling in neural tissues
por: Jung, Eui-Man, et al.
Publicado: (2015)

Unmasking metabolic dependencies in pancreatic cancer: aberrant polyamine synthesis as a promising new therapeutic target
por: Wolters-Eisfeld, Gerrit, et al.
Publicado: (2023)

In search for novel strategies towards neuroprotection and neuroregeneration: is PPARα a promising therapeutic target?
por: Moreno, Sandra, et al.
Publicado: (2015)

Mechanism of action of PD‐1 receptor/ligand targeted cancer immunotherapy [Image: see text]
por: Borst, Jannie, et al.
Publicado: (2021)

OSKM-mediated reversible reprogramming of cardiomyocytes regenerates injured myocardium
por: Farber, Gregory, et al.
Publicado: (2022)

microRNAs become macro players in somatic cell reprogramming
por: Onder, Tamer T, et al.
Publicado: (2011)

Target of Rapamycin Regulates Genome Methylation Reprogramming to Control Plant Growth in Arabidopsis
por: Zhu, Tingting, et al.
Publicado: (2020)

Targeting B cells and plasma cells in autoimmune diseases: From established treatments to novel therapeutic approaches
por: Merino‐Vico, Ana, et al.
Publicado: (2022)

Janus kinase signaling as risk factor and therapeutic target for severe SARS‐CoV‐2 infection
por: Solimani, Farzan, et al.
Publicado: (2021)

Targeting α7 nicotinic acetylcholine receptors: a future potential for neuroprotection from traumatic brain injury
por: Shin, Samuel S., et al.
Publicado: (2015)

Organoid-based chemical approach to dissect the mechanism controlling cellular dynamics
por: Lacko, Lauretta A, et al.
Publicado: (2019)

Targeting viruses in their phase
por: Strzyz, Paulina
Publicado: (2021)

The two faces of invariant natural killer T cells
por: Walton, Emma L.
Publicado: (2015)

Efficient and versatile manipulation of the peripheral CD4(+) T-cell compartment by antigen targeting to DNGR-1/CLEC9A
por: Joffre, Olivier P, et al.
Publicado: (2010)

Towards the Ideal Synthesis of Homoallylic Ketones
por: Ferrer, Sofía, et al.
Publicado: (2015)

Targeting mitochondria as an anticancer strategy
por: Dong, Lanfeng, et al.
Publicado: (2019)

Identifying therapeutic targets for schizophrenia
por: Montague-Cardoso, Karli
Publicado: (2021)

Rapamycin-inspired macrocycles with new target specificity
por: Guo, Zufeng, et al.
Publicado: (2018)

Dietary reprogram of macrophages for cell competition: a promising strategy for malignant cancer control
por: Chen, Jian, et al.
Publicado: (2023)

Machine Learning for Organic Synthesis: Are Robots Replacing Chemists?
por: Maryasin, Boris, et al.
Publicado: (2018)

Human liver organoid: modeling liver steatosis and beyond
por: Wei, Jinsong, et al.
Publicado: (2023)

Directed evolution, natural products for cancer chemotherapy, and micro‐biosensing robots
por: Daniels, Craig, et al.
Publicado: (2011)

Highlight: Gene Cluster Reshuffling Drives Natural Sunscreen Evolution in Lichens
por: McGrath, Casey
Publicado: (2023)

Off-Targeting of Base Editors: BE3 but not ABE induces substantial off-target single nucleotide variants
por: Xin, Huhu, et al.
Publicado: (2019)

Targeting H3K36 methyltransferases NSDs: a promising strategy for tumor targeted therapy
por: Peng, Xuerun, et al.
Publicado: (2021)

Alzheimer’s disease: targeting the peripheral circulation
por: Liu, Zhi-Hao, et al.
Publicado: (2023)

Experimental and natural infections in MyD88‐ and IRAK‐4‐deficient mice and humans
por: von Bernuth, Horst, et al.
Publicado: (2012)

Nanotube‐mediated plasmid transfer as a natural alternative for the improvement of industrially relevant bacteria
por: Molina‐Santiago, Carlos, et al.
Publicado: (2023)

Evaporation-assisted patterning beyond random assembly
por: Duan, Chuanhua
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_l4rj1trd57avs9lhvum2671l34